Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Emerging trends in hepatocellular carcinoma incidence and mortality.

Njei B, Rotman Y, Ditah I, Lim JK.

Hepatology. 2015 Jan;61(1):191-9. doi: 10.1002/hep.27388.

2.

Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States.

Altekruse SF, Henley SJ, Cucinelli JE, McGlynn KA.

Am J Gastroenterol. 2014 Apr;109(4):542-53. doi: 10.1038/ajg.2014.11.

3.
4.

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

Altekruse SF, McGlynn KA, Reichman ME.

J Clin Oncol. 2009 Mar 20;27(9):1485-91. doi: 10.1200/JCO.2008.20.7753.

5.

Mortality and hospital utilization for hepatocellular carcinoma in the United States.

Kim WR, Gores GJ, Benson JT, Therneau TM, Melton LJ 3rd.

Gastroenterology. 2005 Aug;129(2):486-93.

PMID:
16083705
6.

Earlier presentation and application of curative treatments in hepatocellular carcinoma.

Ulahannan SV, Duffy AG, McNeel TS, Kish JK, Dickie LA, Rahma OE, McGlynn KA, Greten TF, Altekruse SF.

Hepatology. 2014 Nov;60(5):1637-44. doi: 10.1002/hep.27288.

7.

Impact of sex on the survival of patients with hepatocellular carcinoma: a Surveillance, Epidemiology, and End Results analysis.

Yang D, Hanna DL, Usher J, LoCoco J, Chaudhari P, Lenz HJ, Setiawan VW, El-Khoueiry A.

Cancer. 2014 Dec 1;120(23):3707-16. doi: 10.1002/cncr.28912.

8.

Trends in esophageal adenocarcinoma incidence and mortality.

Hur C, Miller M, Kong CY, Dowling EC, Nattinger KJ, Dunn M, Feuer EJ.

Cancer. 2013 Mar 15;119(6):1149-58. doi: 10.1002/cncr.27834.

9.

Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.

El-Serag HB, Siegel AB, Davila JA, Shaib YH, Cayton-Woody M, McBride R, McGlynn KA.

J Hepatol. 2006 Jan;44(1):158-66.

PMID:
16290309
10.

Hepatocellular carcinoma in the Netherlands incidence, treatment and survival patterns.

Verhoef C, Visser O, de Man RA, de Wilt JH, IJzermans JN, Janssen-Heijnen ML.

Eur J Cancer. 2004 Jul;40(10):1530-8.

PMID:
15196537
11.

Utilization and outcomes of palliative therapy for hepatocellular carcinoma: a population-based study in the United States.

Davila JA, Duan Z, McGlynn KA, El-Serag HB.

J Clin Gastroenterol. 2012 Jan;46(1):71-7. doi: 10.1097/MCG.0b013e318224d669.

12.

Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases.

Fenoglio L, Serraino C, Castagna E, Cardellicchio A, Pomero F, Grosso M, Senore C.

World J Gastroenterol. 2013 Jun 7;19(21):3207-16. doi: 10.3748/wjg.v19.i21.3207.

13.

Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.

Mathur AK, Osborne NH, Lynch RJ, Ghaferi AA, Dimick JB, Sonnenday CJ.

Arch Surg. 2010 Dec;145(12):1158-63. doi: 10.1001/archsurg.2010.272.

PMID:
21173289
14.

Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.

Weinmann A, Koch S, Niederle IM, Schulze-Bergkamen H, König J, Hoppe-Lotichius M, Hansen T, Pitton MB, Düber C, Otto G, Schuchmann M, Galle PR, Wörns MA.

J Clin Gastroenterol. 2014 Mar;48(3):279-89. doi: 10.1097/MCG.0b013e3182a8a793.

PMID:
24045276
15.
16.

Geographic variation within the United States in the incidence of hepatocellular carcinoma.

Davila JA, Petersena NJ, Nelson HA, El-Serag HB.

J Clin Epidemiol. 2003 May;56(5):487-93.

PMID:
12812824
17.

Comparative and cost effectiveness of treatment modalities for hepatocellular carcinoma in SEER-Medicare.

Shaya FT, Breunig IM, Seal B, Mullins CD, Chirikov VV, Hanna N.

Pharmacoeconomics. 2014 Jan;32(1):63-74. doi: 10.1007/s40273-013-0109-7.

PMID:
24293197
18.

The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update.

El-Serag HB, Davila JA, Petersen NJ, McGlynn KA.

Ann Intern Med. 2003 Nov 18;139(10):817-23. Erratum in: Ann Intern Med. 2004 Jan 20;140(2):151.

PMID:
14623619
19.

Rising incidence of hepatocellular carcinoma in the United States.

El-Serag HB, Mason AC.

N Engl J Med. 1999 Mar 11;340(10):745-50.

20.

Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia.

Nguyen VT, Amin J, Law MG, Dore GJ.

J Gastroenterol Hepatol. 2009 Mar;24(3):436-42. doi: 10.1111/j.1440-1746.2008.05577.x.

PMID:
19175834
Items per page

Supplemental Content

Support Center